Sign in

NOVARTIS AG

Income Statement - NOVARTIS AG (NVS)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14 Dec-13 Dec-12 Dec-11 Dec-10 Dec-09 Dec-08 Dec-07 Dec-06
Total revenue 54.81 51.72 46.66 43.46 43.97 49.90 48.68 46.10 43.40 49.44 50.39 53.63 52.72 51.97 59.38 51.56 45.10 42.58 38.95 35.11
Cost of revenue 13.69 12.83 12.47 11.58 11.74 15.12 14.43 14.51 13.63 17.52 17.40 17.35 16.58 15.87 18.98 14.49 12.18 11.44 11.03 9.41
Gross profit 41.12 38.90 34.19 31.88 32.24 34.78 34.25 31.59 29.77 31.92 32.98 36.29 36.14 36.11 40.39 37.07 32.92 31.15 27.92 25.69
Total operating expenses + 24.05 24.35 24.42 23.93 22.18 24.63 25.17 23.19 21.07 23.65 24.01 25.20 25.15 24.60 29.61 25.55 22.94 22.18 21.13 18.05
Operating income 17.07 14.54 9.77 7.95 10.06 10.15 9.09 8.40 8.70 8.27 8.98 11.09 10.98 11.51 10.78 11.53 9.98 8.96 6.78 7.64
Non-operating income (net) -0.64 -0.90 -0.65 -0.77 14.47 -0.27 -0.15 5.69 0.40 -0.45 -0.84 1.18 -0.18 -0.27 -0.23 0.18 -0.06 0.54 0.71 0.35
Income before tax 16.44 13.64 9.12 7.18 24.53 9.88 8.94 14.10 9.10 7.82 8.13 12.27 10.81 11.24 10.56 11.70 9.92 9.50 7.49 7.99
Income tax expense 2.40 1.70 0.55 1.13 1.63 1.81 1.79 1.30 1.60 1.12 1.11 1.55 1.50 1.71 1.48 1.73 1.47 1.34 0.95 1.17
Net income 14.06 11.94 14.85 6.96 24.02 8.07 11.73 12.61 7.70 6.71 17.78 10.21 9.18 9.27 8.94 9.79 8.40 8.20 11.95 7.18
Show Quarterly Income Statement

Income Statement - NOVARTIS AG (NVS)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18 Dec-17 Sep-17 Jun-17 Mar-17 Dec-16 Sep-16 Jun-16 Mar-16 Dec-15 Sep-15 Jun-15 Mar-15 Dec-14 Sep-14 Jun-14 Mar-14 Dec-13 Sep-13 Jun-13 Mar-13 Dec-12 Sep-12 Jun-12 Mar-12 Dec-11 Sep-11 Jun-11 Mar-11 Dec-10 Sep-10 Jun-10 Mar-10 Dec-09 Sep-09 Jun-09 Mar-09 Dec-08 Sep-08 Jun-08 Mar-08 Dec-07 Sep-07 Jun-07 Mar-07 Dec-06 Sep-06 Jun-06 Mar-06
Total revenue 13.52 13.33 14.36 14.84 13.62 13.56 13.17 12.87 12.12 11.78 12.09 11.75 11.05 13.09 10.78 13.09 12.81 13.52 13.37 13.29 12.69 13.03 12.54 11.62 12.71 12.72 12.48 12.02 11.46 13.66 11.39 11.65 11.16 13.16 12.69 12.49 11.79 12.61 12.34 12.68 11.81 12.80 12.49 12.90 12.20 13.35 13.30 13.95 13.03 15.36 12.91 13.28 14.21 15.07 14.04 14.54 13.91 15.00 15.03 15.12 14.22 14.46 12.82 11.92 12.36 13.15 11.29 10.74 9.93 10.35 11.03 10.99 10.22 10.17 9.82 9.40 9.37 9.32 9.02 8.51 8.15
Cost of revenue 3.46 3.54 3.54 3.32 3.23 3.32 3.23 3.17 3.10 3.02 3.12 3.34 2.99 4.07 2.87 3.75 3.86 3.98 3.94 3.91 4.04 4.22 3.75 3.43 3.72 3.99 3.78 3.41 3.25 4.93 3.46 3.56 3.45 4.49 4.32 4.26 4.11 4.49 4.37 4.45 4.21 4.55 4.39 4.49 3.98 4.42 4.42 4.38 4.13 5.31 4.13 4.09 4.61 5.09 4.58 4.61 4.48 5.12 4.79 4.62 4.46 4.52 3.66 3.21 3.10 3.67 3.10 2.82 2.81 2.83 3.02 2.94 2.65 3.01 3.03 2.50 2.49 2.51 2.53 2.23 2.18
Gross profit 10.07 9.79 10.82 11.51 10.39 10.23 9.94 9.70 9.02 8.75 8.98 8.40 8.06 9.01 7.91 9.33 8.96 9.55 9.43 9.38 8.66 8.81 8.79 8.19 8.99 8.72 8.71 8.62 8.20 8.74 7.92 8.10 7.71 8.68 8.37 8.24 7.68 8.12 7.97 8.23 7.60 8.26 8.10 8.41 8.22 8.94 8.88 9.57 8.90 10.05 8.78 9.19 9.60 9.98 9.46 9.93 9.43 9.88 10.25 10.50 9.76 9.94 9.16 8.72 9.26 9.48 8.19 7.92 7.12 7.51 8.01 8.05 7.57 7.16 6.78 6.90 6.89 6.81 6.50 6.28 5.97
Total operating expenses + 5.83 6.27 6.32 6.65 5.73 6.70 6.31 5.69 5.65 6.17 7.21 5.60 5.44 7.07 6.08 7.11 6.11 6.98 6.20 5.90 6.24 6.17 6.37 5.84 6.24 6.90 6.35 5.96 5.96 7.44 5.68 5.66 5.34 6.61 6.01 5.96 5.76 6.66 5.70 6.14 5.15 6.58 5.86 6.13 5.44 6.59 6.14 6.39 6.09 7.68 6.22 6.16 6.70 7.50 6.52 6.82 6.69 8.56 7.30 7.18 6.36 7.47 6.57 5.75 5.75 6.84 5.55 5.55 4.77 5.83 5.67 5.59 5.08 6.85 4.74 4.67 4.55 5.21 4.52 4.06 3.91
Operating income 4.24 3.52 4.50 4.86 4.66 3.53 3.63 4.01 3.37 2.58 1.76 2.81 2.62 1.95 1.83 2.23 2.85 2.56 3.23 3.48 2.42 2.64 2.41 2.35 2.74 1.82 2.36 2.66 2.24 1.30 2.24 2.43 2.37 2.07 2.36 2.28 1.92 1.46 2.27 2.09 2.45 1.68 2.23 2.28 2.79 2.35 2.74 3.18 2.82 2.37 2.56 3.03 2.90 2.48 2.95 3.11 2.74 1.32 2.95 3.32 3.41 2.47 2.59 2.96 3.51 2.64 2.63 2.36 2.35 1.68 2.34 2.46 2.49 0.31 2.04 2.23 2.34 1.60 1.98 2.23 2.06
Non-operating income (net) -0.40 -0.30 -0.31 -0.33 -0.26 -0.25 -0.24 -0.17 -0.24 -0.21 -0.21 -0.13 -0.10 -0.21 -0.24 -0.19 -0.18 14.39 0.00 0.03 0.04 -0.09 0.00 -0.06 -0.12 -0.06 0.05 -0.03 -0.10 -0.04 0.01 5.74 -0.03 0.23 0.08 0.04 0.03 -0.38 0.01 0.02 -0.10 -0.55 -0.07 -0.13 -0.11 0.41 0.79 -0.04 0.02 -0.05 -0.07 0.00 -0.06 -0.05 -0.17 0.03 -0.08 -0.06 -0.04 -0.08 -0.05 -0.05 0.21 0.00 0.02 0.06 -0.14 0.08 -0.05 0.08 0.09 0.14 0.23 0.88 -0.47 0.00 0.13 0.11 0.08 -0.26 0.15
Income before tax 3.84 3.22 4.20 4.53 4.41 3.29 3.39 3.84 3.13 2.38 1.55 2.67 2.52 1.74 1.59 2.04 2.67 16.95 3.23 3.51 2.45 2.56 2.41 2.29 2.62 1.76 2.41 2.63 2.14 1.26 2.25 8.17 2.34 2.30 2.44 2.32 1.95 1.08 2.27 2.11 2.35 1.13 2.17 2.16 2.68 2.76 3.53 3.15 2.84 2.32 2.49 3.03 2.84 2.43 2.78 3.14 2.66 1.26 2.91 3.25 3.36 2.42 2.79 2.96 3.53 2.69 2.49 2.44 2.30 1.76 2.42 2.60 2.72 1.19 1.57 2.23 2.47 1.71 2.06 1.97 2.21
Income tax expense 0.68 0.81 0.27 0.51 0.80 0.47 0.20 0.60 0.44 -0.26 0.04 0.40 0.37 0.28 0.26 0.35 0.45 0.65 0.47 0.61 0.39 0.46 0.48 0.42 0.45 0.63 0.37 0.53 0.27 0.07 0.37 0.44 0.37 0.33 0.35 0.34 0.28 0.14 0.33 0.31 0.34 0.08 0.36 0.30 0.37 0.31 0.43 0.42 0.38 0.26 0.33 0.45 0.42 0.35 0.36 0.46 0.39 0.05 0.42 0.52 0.54 0.16 0.48 0.52 0.58 0.37 0.38 0.40 0.32 0.25 0.34 0.34 0.41 0.25 0.04 0.28 0.37 0.23 0.27 0.32 0.37
Net income 3.16 2.41 3.93 4.04 3.61 2.82 3.19 3.25 2.69 8.48 1.76 2.32 2.29 1.47 1.57 1.69 2.22 16.31 2.76 2.90 2.06 2.09 1.94 1.87 2.18 1.13 2.04 6.80 1.77 1.20 1.62 7.77 2.03 1.98 2.08 1.98 1.67 0.96 1.94 1.80 2.01 1.05 1.89 1.84 13.01 1.49 3.22 2.56 2.94 2.03 2.23 2.52 2.40 2.05 2.39 2.65 2.25 1.18 2.46 2.70 2.77 2.17 2.28 2.42 2.93 2.31 2.10 2.04 1.96 1.54 2.09 2.25 2.32 0.90 6.87 2.01 2.17 1.65 1.87 1.71 1.95
about 2 months ago

Balance Sheet - NOVARTIS AG (NVS)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14 Dec-13 Dec-12 Dec-11 Dec-10 Dec-09 Dec-08 Dec-07 Dec-06
Total cash and short-term investments + 11.59 13.35 13.96 18.62 28.11 11.56 11.45 15.96 9.49 7.78 5.45 13.86 9.22 8.12 5.08 8.13 17.45 6.12 13.20 7.96
Accounts receivable, net 10.93 8.21 9.38 9.89 9.62 9.07 9.17 9.68 10.07 10.20 10.55 10.26 12.62 12.53 12.37 11.72 10.01 8.57 8.50 7.97
Inventories 6.27 5.72 5.91 7.18 6.67 7.13 5.98 6.96 6.87 6.26 6.23 6.09 7.27 6.74 5.93 6.09 5.83 5.79 5.46 4.50
Other current assets 1.67 2.42 1.23 1.23 1.32 1.91 2.90 4.05 1.79 0.70 0.62 7.35 1.43 0.61 0.71 0.74 0.40 0.40 0.27 0.98
Total current assets 30.46 29.70 30.48 36.91 45.72 29.67 29.50 35.56 28.21 24.93 22.85 37.56 30.54 28.00 24.08 26.69 33.69 20.88 27.43 21.40
Total non-current assets + 85.11 72.54 69.46 80.54 86.08 102.52 88.91 110.00 104.87 105.19 108.71 87.83 95.71 96.21 93.41 96.63 61.81 57.42 48.02 46.60
Total assets 115.57 102.25 99.95 117.45 131.80 132.19 118.41 145.56 133.08 130.12 131.56 125.39 126.25 124.22 117.50 123.32 95.51 78.30 75.45 68.01
Total current liabilities + 27.28 28.69 26.39 28.66 30.21 33.06 28.26 29.61 23.40 22.21 23.71 26.97 26.37 24.05 23.15 24.66 19.47 16.50 16.64 16.23
Total non-current liabilities + 41.74 29.43 26.81 29.37 33.77 42.46 34.60 37.26 35.45 33.02 30.73 27.57 25.41 30.95 28.41 28.89 18.57 11.36 9.42 10.48
Total liabilities 69.02 58.12 53.20 58.03 63.97 75.52 62.86 66.87 58.85 55.23 54.43 54.54 51.78 55.00 51.56 53.55 38.04 27.86 26.06 26.71
Total stockholders' equity + 46.13 44.05 46.67 59.34 67.66 56.60 55.47 78.61 74.17 74.83 77.05 70.77 74.34 69.09 65.84 63.20 57.39 50.29 49.22 41.11
Common shares outstanding 1,955 2,035 2,092 2,197 2,260 2,296 2,319 2,344 2,371 2,400 2,438 2,470 2,479 2,445 2,413 2,301 2,277 2,284 2,329 2,360
Show Quarterly Balance Sheet

Balance Sheet - NOVARTIS AG (NVS)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18 Dec-17 Sep-17 Jun-17 Mar-17 Dec-16 Sep-16 Jun-16 Mar-16 Dec-15 Sep-15 Jun-15 Mar-15 Dec-14 Sep-14 Jun-14 Mar-14 Dec-13 Sep-13 Jun-13 Mar-13 Dec-12 Sep-12 Jun-12 Mar-12 Dec-11 Sep-11 Jun-11 Mar-11 Dec-10 Sep-10 Jun-10 Mar-10 Dec-09 Sep-09 Jun-09 Mar-09 Dec-08 Sep-08 Jun-08 Mar-08 Dec-07 Sep-07 Jun-07 Mar-07 Dec-06 Sep-06 Jun-06 Mar-06
Total cash and short-term investments + 6.98 11.59 9.75 7.00 7.20 13.35 14.02 8.44 9.69 14.43 12.70 11.17 12.26 18.93 19.10 19.76 18.81 28.33 8.16 5.36 4.08 11.56 10.87 6.29 4.97 11.45 8.72 10.34 7.11 15.96 14.71 13.15 6.42 9.49 9.40 8.42 8.24 7.78 7.74 5.65 5.07 5.45 5.93 5.81 8.25 13.86 10.43 7.32 7.72 9.22 7.27 5.09 6.04 8.12 5.80 6.11 5.39 5.08 5.57 5.60 8.76 8.13 7.99 23.00 19.90 17.45 14.17 11.82 7.84 6.12 8.14 16.20 10.85 13.20 14.53 7.55 6.96 7.96 8.53 7.31 11.12
Accounts receivable, net 9.60 10.93 8.98 9.18 8.73 8.21 8.15 8.48 8.25 8.12 7.10 9.54 9.18 8.94 8.68 8.91 8.68 8.83 8.63 8.65 8.48 9.07 8.30 7.95 8.80 9.17 8.07 8.25 7.85 9.68 8.77 8.99 9.12 10.07 8.48 8.38 8.23 10.20 8.55 8.61 8.46 8.18 8.50 8.75 8.79 10.26 8.86 9.37 10.32 9.90 10.50 10.79 10.48 11.11 10.52 10.49 10.61 12.37 10.70 10.92 10.86 11.72 10.39 7.80 7.77 10.01 7.82 7.17 6.75 8.57 7.25 7.14 6.88 8.50 6.81 6.23 6.35 7.97 6.09 5.89 5.29
Inventories 6.29 6.27 6.42 6.31 5.83 5.72 5.94 5.75 5.74 5.91 5.61 8.23 7.89 7.18 6.78 6.88 7.00 6.67 6.89 7.11 7.00 7.13 7.14 6.90 6.40 5.98 6.12 6.09 5.73 6.96 6.95 7.10 7.23 6.87 6.95 6.90 6.58 6.26 6.77 6.67 6.63 6.23 6.56 6.61 6.27 6.09 6.51 6.88 7.86 7.27 7.52 7.26 7.02 6.74 6.85 6.42 6.46 5.93 6.61 7.10 6.62 6.09 6.76 5.54 5.66 5.83 6.31 6.13 5.76 5.79 5.96 6.45 6.24 5.46 5.27 5.02 4.98 4.50 4.61 4.69 3.93
Other current assets 3.74 1.72 3.04 3.46 3.36 2.42 3.16 3.03 2.76 2.02 20.26 4.55 2.79 1.87 2.39 2.59 2.75 1.90 2.57 2.69 2.64 1.91 2.67 2.73 2.93 2.90 3.77 3.64 31.76 4.05 3.69 2.83 10.29 1.79 2.61 2.82 2.71 0.70 2.78 2.79 2.83 2.99 3.06 3.57 3.28 9.69 10.99 11.41 3.78 3.39 3.48 3.70 3.26 3.09 8.78 9.22 8.72 0.71 8.26 8.62 11.62 0.74 10.57 25.33 22.37 0.40 16.32 13.88 9.97 0.40 1.95 2.30 2.31 0.27 2.07 1.83 3.04 0.98 1.75 1.91 1.58
Total current assets 26.61 30.46 28.20 25.94 25.11 29.70 31.26 25.69 26.45 30.48 45.66 33.49 32.11 36.91 36.95 38.14 37.24 45.72 26.25 23.81 22.20 29.67 28.97 23.88 23.10 29.50 26.68 28.32 52.45 35.56 34.11 32.07 33.05 28.21 27.47 26.54 25.77 24.93 25.88 23.72 22.99 22.85 24.05 24.75 25.71 37.56 36.79 34.97 29.69 30.54 28.77 26.85 26.80 28.00 26.15 26.12 25.79 24.08 25.56 26.63 29.10 26.69 27.72 38.67 35.80 33.69 30.44 27.17 22.48 20.88 23.30 32.09 26.29 27.43 28.68 20.64 21.33 21.40 20.97 19.80 21.92
Total non-current assets + 91.93 85.11 79.09 78.46 74.83 72.54 72.26 71.81 67.89 73.34 67.04 77.49 80.13 84.86 81.51 84.77 87.98 90.17 94.96 100.21 99.55 102.52 100.71 99.88 100.00 88.91 89.30 87.97 85.50 110.00 108.88 109.99 102.47 104.87 107.51 107.21 106.22 105.19 108.12 107.71 109.46 108.71 108.88 110.67 109.23 87.83 88.59 90.80 95.64 95.71 95.82 94.23 94.22 96.21 95.07 92.37 93.62 93.41 95.81 99.29 98.12 96.63 96.91 58.26 60.00 61.81 60.25 57.10 55.49 57.42 58.72 51.31 50.03 48.02 48.25 49.98 46.99 46.60 45.89 46.13 36.93
Total assets 118.53 115.57 107.29 104.40 99.94 102.25 103.52 97.51 94.33 103.82 112.70 110.98 112.24 121.77 118.46 122.91 125.22 135.88 121.21 124.02 121.75 132.19 129.68 123.76 123.10 118.41 115.97 116.29 137.95 145.56 142.99 142.06 135.52 133.08 134.97 133.75 131.99 130.12 134.01 131.44 132.45 131.56 132.93 135.41 134.94 125.39 125.38 125.77 125.33 126.25 124.59 121.07 121.01 124.22 121.22 118.49 119.41 117.50 121.38 125.92 127.22 123.32 124.63 96.92 95.80 95.51 90.69 84.27 77.97 78.30 82.02 83.40 76.32 75.45 76.94 70.62 68.32 68.01 66.86 65.93 58.85
Total current liabilities + 31.37 27.28 32.00 31.71 31.62 28.69 28.13 27.61 29.29 26.39 48.39 31.91 30.55 28.66 28.16 27.65 29.81 30.21 29.88 29.63 30.16 33.06 31.84 29.38 31.29 28.26 28.22 30.11 56.13 29.61 28.33 27.94 28.22 23.40 25.38 26.15 26.33 22.21 24.60 26.27 27.82 23.71 28.16 29.39 29.05 26.97 26.62 27.56 24.76 26.37 25.81 24.39 26.37 24.05 21.86 24.92 27.36 23.15 25.83 29.54 32.22 24.66 27.66 17.83 17.43 19.47 17.90 15.36 14.99 16.50 19.95 19.68 17.06 16.64 17.50 15.98 17.55 16.23 16.32 16.76 15.59
Total non-current liabilities + 48.23 41.74 30.54 30.63 29.87 29.43 31.95 27.99 25.29 30.68 26.06 27.14 29.55 33.69 29.41 32.26 33.71 37.85 34.39 40.25 41.00 42.46 43.29 40.50 40.83 34.60 35.15 34.68 34.51 37.26 36.65 37.21 36.09 35.45 37.22 37.63 38.01 33.02 34.34 32.63 32.74 30.73 27.98 27.19 29.44 27.57 27.34 27.70 30.24 25.41 26.60 27.06 27.49 30.95 32.16 29.33 28.85 28.41 29.41 29.29 29.66 28.89 30.75 23.28 23.15 18.57 19.47 18.43 16.75 11.36 11.33 12.11 10.00 9.42 9.94 10.98 10.27 10.48 11.96 12.01 9.50
Total liabilities 79.61 69.02 62.54 62.34 61.49 58.12 60.08 55.60 54.58 57.07 74.45 59.05 60.10 62.34 57.57 59.90 63.51 68.06 64.27 69.89 71.16 75.52 75.12 69.88 72.12 62.86 63.37 64.79 90.64 66.87 64.98 65.16 64.31 58.85 62.60 63.77 64.34 55.23 58.94 58.90 60.56 54.43 56.14 56.58 58.49 54.54 53.95 55.25 55.00 51.78 52.42 51.44 53.86 55.00 54.01 54.25 56.21 51.56 55.24 58.82 61.88 53.55 58.41 41.11 40.58 38.04 37.37 33.79 31.74 27.86 31.28 31.79 27.05 26.06 27.44 26.96 27.82 26.71 28.27 28.77 25.09
Total stockholders' equity + 38.51 46.13 44.33 41.99 38.37 44.05 43.32 41.73 39.68 46.67 38.16 51.85 52.06 59.34 60.82 62.93 61.54 67.66 56.77 54.04 50.52 56.60 54.48 53.81 50.90 55.47 52.52 51.43 47.23 78.61 77.94 76.82 71.10 74.17 72.31 69.92 67.59 74.83 74.98 72.46 71.81 77.05 76.71 78.76 76.38 70.77 71.34 70.39 70.21 74.34 72.05 69.49 67.03 69.09 67.08 64.13 63.11 65.84 66.14 67.09 65.34 63.20 66.22 55.82 55.22 57.39 53.31 50.49 46.23 50.29 50.74 51.61 49.27 49.22 49.49 43.66 40.50 41.11 38.59 37.16 33.75
Common shares outstanding 1,916 1,929 1,940 1,960 1,979 2,004 2,027 2,046 2,056 2,065 2,075 2,095 2,120 2,150 2,180 2,211 2,237 2,253 2,254 2,258 2,265 2,282 2,302 2,304 2,292 2,292 2,297 2,333 2,339 2,336 2,338 2,346 2,347 2,348 2,359 2,373 2,389 2,395 2,401 2,401 2,398 2,418 2,438 2,451 2,446 2,449 2,460 2,471 2,479 2,469 2,480 2,490 2,473 2,451 2,445 2,441 2,435 2,424 2,450 2,426 2,305 2,288 2,300 2,297 2,290 2,268 2,285 2,280 2,283 2,264 2,283 2,286 2,273 2,312 2,322 2,352 2,359 2,348 2,362 2,362 2,355
about 2 months ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14 Dec-13 Dec-12 Dec-11 Dec-10 Dec-09 Dec-08 Dec-07 Dec-06
Operating cash flow + 19.24 17.62 14.46 14.24 15.07 13.65 13.63 14.27 12.62 11.48 11.90 13.90 13.17 14.19 14.31 14.07 12.19 9.77 9.21 8.71
Cash flow from investing + -4.90 -7.51 5.60 1.47 4.21 -13.18 -2.23 -5.59 -3.12 -3.44 -10.78 0.88 -3.35 -5.68 -0.79 -15.76 -14.22 -10.37 -6.24 -6.58
Cash flow from financing + -14.94 -11.74 -14.28 -20.56 -16.26 -2.21 -13.63 -4.24 -7.73 -5.31 -9.18 -8.15 -8.77 -6.68 -15.02 4.12 2.81 -2.57 -9.32 -4.97
Change in cash -0.60 -1.64 5.78 -4.86 3.02 -1.74 -2.23 4.44 1.77 2.72 -8.06 6.63 1.05 1.84 -1.51 2.43 0.78 -3.17 -6.35 -2.84
Show Quarterly Cash Flow
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18 Dec-17 Sep-17 Jun-17 Mar-17 Dec-16 Sep-16 Jun-16 Mar-16 Dec-15 Sep-15 Jun-15 Mar-15 Dec-14 Sep-14 Jun-14 Mar-14 Dec-13 Sep-13 Jun-13 Mar-13 Dec-12 Sep-12 Jun-12 Mar-12 Dec-11 Sep-11 Jun-11 Mar-11 Dec-10 Sep-10 Jun-10 Mar-10 Dec-09 Sep-09 Jun-09 Mar-09 Dec-08 Sep-08 Jun-08 Mar-08 Dec-07 Sep-07 Jun-07 Mar-07 Dec-06 Sep-06 Jun-06 Mar-06
Operating cash flow + 3.68 2.25 6.57 6.66 3.65 4.19 6.29 4.88 2.27 2.55 5.38 3.58 2.96 4.11 4.72 3.76 1.65 3.88 4.93 4.13 2.13 4.01 3.16 3.96 2.53 3.54 4.56 3.11 2.41 3.77 4.05 3.94 2.51 3.41 3.59 3.58 2.05 3.59 3.23 3.11 1.54 4.16 3.13 2.91 1.70 5.21 4.01 3.34 1.34 4.45 4.38 2.52 1.83 4.63 4.07 2.99 2.52 4.72 4.23 3.45 1.91 4.58 3.23 2.96 3.31 4.47 3.15 2.62 1.95 3.28 2.88 1.87 1.74 -5.02 10.19 1.81 2.22 2.29 2.52 1.76 2.14
Cash flow from investing + -11.74 -2.11 -0.86 -2.24 0.33 -3.03 -0.37 -3.21 -0.90 -1.11 -2.21 -1.05 10.62 -1.47 5.20 -11.63 9.37 4.56 -1.23 0.10 0.78 -0.57 -2.05 -0.43 -10.14 0.32 -3.40 -0.47 1.33 -4.94 -0.89 4.33 -4.10 -1.00 -0.69 -0.34 -1.10 -1.07 -0.75 -0.84 -0.77 -1.69 -0.75 -1.78 -6.56 -0.92 0.05 -1.08 2.82 -2.66 -0.75 -0.64 0.70 -2.54 -1.97 -0.72 -0.45 -0.82 -0.57 0.11 0.49 -0.59 -10.66 -3.37 -1.14 -4.19 -4.45 -2.73 -2.84 -1.73 -13.12 1.05 3.43 -1.68 -2.59 -0.73 -1.25 -0.83 -0.48 -5.02 -0.24
Cash flow from financing + 3.58 1.71 -2.79 -5.21 -8.55 -3.00 -0.38 -3.20 -5.16 -0.61 -0.83 -3.64 -9.20 -3.99 -4.74 -2.30 -9.53 -3.25 -1.53 -2.94 -8.54 -2.94 1.90 -2.19 1.01 -1.20 -2.71 -0.03 -9.68 0.45 -1.62 -1.53 -1.55 -2.40 -1.94 -3.01 -0.39 -2.30 -0.34 -1.64 -1.03 -2.78 -2.20 -2.45 -1.76 -0.74 -1.08 -2.64 -3.69 -1.52 -1.39 -2.52 -3.34 -1.14 -2.12 -1.67 -1.74 -4.22 -3.76 -6.56 -0.49 -4.06 7.20 0.95 0.02 -0.14 0.44 2.06 0.45 -3.75 0.69 4.18 -3.69 -3.16 -2.87 -0.81 -2.48 -1.94 -0.46 -0.82 -1.75
Change in cash -4.48 1.86 2.92 -0.79 -4.57 -1.84 5.53 -1.53 -3.80 0.83 2.33 -1.11 4.38 -1.35 5.18 -10.18 1.49 5.20 2.16 1.29 -5.63 0.50 3.01 1.35 -6.60 2.66 -1.55 2.61 -5.94 -0.72 1.54 6.74 -3.13 0.02 0.96 0.23 0.56 0.22 2.14 0.63 -0.26 -0.31 0.18 -1.32 -6.61 3.54 2.99 -0.38 0.48 0.28 2.23 -0.64 -0.82 0.95 -0.02 0.59 0.33 -0.32 -0.10 -3.00 1.91 -0.07 -0.23 0.54 2.19 0.13 -0.86 1.94 -0.44 -2.19 -9.56 7.10 1.49 -9.85 4.73 0.28 -1.51 -0.48 1.58 -4.08 0.16
about 2 months ago

NOVARTIS AG (NVS) - Total Non Current Assets

1Y 2Y 5Y Max
about 2 months ago

NOVARTIS AG (NVS) - Current Net Receivables

1Y 2Y 5Y Max
about 2 months ago

NOVARTIS AG (NVS) - Inventory

1Y 2Y 5Y Max
about 2 months ago

NOVARTIS AG (NVS) - Cash And Short Term Investments

1Y 2Y 5Y Max
about 2 months ago

NOVARTIS AG (NVS) - Cash And Cash Equivalents At Carrying Value

1Y 2Y 5Y Max
about 2 months ago

NOVARTIS AG (NVS) - Total Current Assets

1Y 2Y 5Y Max
about 2 months ago

NOVARTIS AG (NVS) - Total Assets

1Y 2Y 5Y Max
about 2 months ago

NOVARTIS AG (NVS) - Treasury Stock

1Y 2Y 5Y Max
about 2 months ago

NOVARTIS AG (NVS) - Common Stock Shares Outstanding

1Y 2Y 5Y Max
about 2 months ago

NOVARTIS AG (NVS) - Common Stock

1Y 2Y 5Y Max
about 2 months ago